Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Foster

Showing results (181-190 of 205) with videos related to

Pageof 21
Sort By:
Basic & Clinical Pharmacology & Toxicology|August 29, 2014
Pharmacodynamic modelling of placebo and buprenorphine effects on event-related potentials in experimental painRasmus V Juul, David J R Foster, Richard N Upton, et al.
Journal of Clinical Pharmacology|April 29, 2008
Pharmacokinetic-pharmacodynamic modeling of morphine and oxycodone concentrations and analgesic effect in a multimodal experimental pain modelCamilla Staahl, Richard Upton, David J R Foster, et al.
Basic & Clinical Pharmacology & Toxicology|July 5, 2008
Pharmacokinetic-pharmacodynamic relationships of cognitive and psychomotor effects of intravenous buprenorphine infusion in human volunteersMette L Jensen, Per Sjøgren, Richard N Upton, et al.
Therapeutic Advances in Musculoskeletal Disease|July 28, 2022
The association of depression and anxiety with treatment outcomes in patients with rheumatoid arthritis - a pooled analysis of five randomised controlled trialsArkady T Manning-Bennett, Ashley M Hopkins, Michael J Sorich, et al.
The AAPS Journal|January 29, 2020
Demonstrating Contribution of Components of Fixed-Dose Drug Combinations Through Longitudinal Exposure-Response AnalysisAsbjørn Nøhr-Nielsen, Theis Lange, Julie Lyng Forman, et al.
British Journal of Cancer|July 7, 2005
Assessing proliferation, cell-cycle arrest and apoptotic end points in human buccal punch biopsies for use as pharmacodynamic biomarkers in drug developmentD R Camidge, M N Pemberton, J W Growcott, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 7, 2016
Modelling the PKPD of oxycodone in experimental pain - Impact of opioid receptor polymorphismsRasmus Olsen, David J R Foster, Richard N Upton, et al.
Basic & Clinical Pharmacology & Toxicology|October 10, 2019
Population pharmacokinetic-pharmacodynamic modelling of liquid and controlled-release formulations of oxycodone in healthy volunteersLouise Ladebo, David J R Foster, Ahmad Y Abuhelwa, et al.
The American Journal of Cardiology|October 1, 1973
Survival after massive procainamide ingestionL Villalba-Pimentel, L M Epstein, E M Sellers, et al.
Biochemical Pharmacology|December 15, 1986
Immunocytochemical localization of cytochrome P-450 in hepatic and extra-hepatic tissues of the rat with a monoclonal antibody against cytochrome P-450 cJ R Foster, C R Elcombe, A R Boobis, et al.
Pageof 21

Showing results (181-190 of 205) with videos related to

Sort By:
Pageof 21
Basic & Clinical Pharmacology & Toxicology|August 29, 2014
Pharmacodynamic modelling of placebo and buprenorphine effects on event-related potentials in experimental painRasmus V Juul, David J R Foster, Richard N Upton, et al.
Journal of Clinical Pharmacology|April 29, 2008
Pharmacokinetic-pharmacodynamic modeling of morphine and oxycodone concentrations and analgesic effect in a multimodal experimental pain modelCamilla Staahl, Richard Upton, David J R Foster, et al.
Basic & Clinical Pharmacology & Toxicology|July 5, 2008
Pharmacokinetic-pharmacodynamic relationships of cognitive and psychomotor effects of intravenous buprenorphine infusion in human volunteersMette L Jensen, Per Sjøgren, Richard N Upton, et al.
Therapeutic Advances in Musculoskeletal Disease|July 28, 2022
The association of depression and anxiety with treatment outcomes in patients with rheumatoid arthritis - a pooled analysis of five randomised controlled trialsArkady T Manning-Bennett, Ashley M Hopkins, Michael J Sorich, et al.
The AAPS Journal|January 29, 2020
Demonstrating Contribution of Components of Fixed-Dose Drug Combinations Through Longitudinal Exposure-Response AnalysisAsbjørn Nøhr-Nielsen, Theis Lange, Julie Lyng Forman, et al.
British Journal of Cancer|July 7, 2005
Assessing proliferation, cell-cycle arrest and apoptotic end points in human buccal punch biopsies for use as pharmacodynamic biomarkers in drug developmentD R Camidge, M N Pemberton, J W Growcott, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 7, 2016
Modelling the PKPD of oxycodone in experimental pain - Impact of opioid receptor polymorphismsRasmus Olsen, David J R Foster, Richard N Upton, et al.
Basic & Clinical Pharmacology & Toxicology|October 10, 2019
Population pharmacokinetic-pharmacodynamic modelling of liquid and controlled-release formulations of oxycodone in healthy volunteersLouise Ladebo, David J R Foster, Ahmad Y Abuhelwa, et al.
The American Journal of Cardiology|October 1, 1973
Survival after massive procainamide ingestionL Villalba-Pimentel, L M Epstein, E M Sellers, et al.
Biochemical Pharmacology|December 15, 1986
Immunocytochemical localization of cytochrome P-450 in hepatic and extra-hepatic tissues of the rat with a monoclonal antibody against cytochrome P-450 cJ R Foster, C R Elcombe, A R Boobis, et al.
Pageof 21